GLUCOSE B. BRAUN 200 mg/ml (20 %) raztopina za injiciranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

glucose b. braun 200 mg/ml (20 %) raztopina za injiciranje

medis, d.o.o. - glukoza - raztopina za injiciranje - glukoza 200 mg / 1 ml - ogljikovi hidrati

GLUCOSE B. BRAUN 400 mg/ml (40 %) koncentrat za raztopino za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

glucose b. braun 400 mg/ml (40 %) koncentrat za raztopino za infundiranje

medis, d.o.o. - glukoza - koncentrat za raztopino za infundiranje - glukoza 400 mg / 1 ml - ogljikovi hidrati

Edistride Evropska unija - slovenščina - EMA (European Medicines Agency)

edistride

astrazeneca ab - dapagliflozin propandiol monohidrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - zdravila, ki se uporabljajo pri diabetesu - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. poleg drugimi zdravili za zdravljenje diabetesa tipa 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 in 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.

Forxiga Evropska unija - slovenščina - EMA (European Medicines Agency)

forxiga

astrazeneca ab - dapagliflozin propandiol monohidrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - zdravila, ki se uporabljajo pri diabetesu - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. poleg drugimi zdravili za zdravljenje diabetesa tipa 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 in 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.

Invokana Evropska unija - slovenščina - EMA (European Medicines Agency)

invokana

janssen-cilag international nv - kanaglifozin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - invokana is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:as monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 in 5.

Qtern Evropska unija - slovenščina - EMA (European Medicines Agency)

qtern

astra zeneca ab - saxagliptin, dapagliflozin propanediol monohidrat - diabetes mellitus, type 2; diabetes mellitus; nutritional and metabolic diseases; metabolic diseases; glucose metabolism disorders - zdravila, ki se uporabljajo pri diabetesu - qtern, fiksni odmerek kombinacija saxagliptin in dapagliflozin, je navedeno pri odraslih, starih 18 let in več, z vrsto 2 sladkorna bolezen:za izboljšanje glycaemic nadzor, ko metforminom in/ali sulfonil sečnine (su) in eden od monocomponents od qtern ne zagotavljajo ustrezne glycaemic nadzor,ko se že zdravijo z brezplačno kombinacija dapagliflozin in saxagliptin. (glej točki 4. 2, 4. 4, 4. 5 in 5. 1, če so na voljo podatki o kombinacije študiral.

GLUCOSE 5% EP 50/100 Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

glucose 5% ep 50/100

raztopina za infundiranje - raztopine in pripravki za redčenje, vključno s tekočinami za izpiranje

GLUCOSE B. BRAUN 50 mg/ml (5 %) raztopina za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

glucose b. braun 50 mg/ml (5 %) raztopina za infundiranje

medis, d.o.o. - raztopina za infundiranje - ogljikovi hidrati

GLUCOSE 5% B.Braun Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

glucose 5% b.braun

medis, d.o.o. - raztopina za infundiranje - ogljikovi hidrati

Kalijev klorid/glukoza Kabi 1,5 mg/50 mg v 1 ml raztopina za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kalijev klorid/glukoza kabi 1,5 mg/50 mg v 1 ml raztopina za infundiranje

fresenius kabi deutschland gmbh - glukoza; kalijev klorid - raztopina za infundiranje - glukoza 50 mg / 1 ml  kalijev klorid1,5 mg / 1 ml; kalijev klorid 1,5 mg / 1 ml - elektroliti z ogljikovimi hidrati